11:42 AM EDT, 06/17/2025 (MT Newswires) -- Jyong Biotech (MENS) shares more than doubled to $16.05 in their debut Tuesday on Nasdaq after the company priced its initial public offering of 2.67 million ordinary shares at $7.50 each.

The stock opened at $15 and earlier rose as high as $19.99.

The underwriters have a 45-day option to buy up to an additional 400,000 shares to cover any overallotments, the company said Tuesday.

The company plans to use the net proceeds of $20 million for clinical trials, the new drug application of its lead botanical drug candidate, and general corporate purposes

Price: 16.05, Change: +8.55, Percent Change: +114.00